CpG oligodeoxynucleotide induction of antiviral effector molecules in sheep

Cellular Immunology

Volumn 227, Issue 1, 2004, Pages 24-37

  Nichani, Anil K ^a   Kaushik, Radhey S ^a,c   Mena, Angelo ^a   Popowych, Yurij ^a   Dent, Donna ^a   Townsend, Hugh G G ^a   Mutwiri, George ^a   Hecker, Rolf ^b   Babiuk, Lorne A ^a   Griebel, Philip J ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b QIAGEN GMBH   (Germany)

^c SOUTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

2 5 A synthetase; CpG ODN; IFN ; IFN ; MHC class II; Sheep

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; ALPHA INTERFERON; CPG OLIGODEOXYNUCLEOTIDE; GAMMA INTERFERON; OLIGODEOXYNUCLEOTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL INFILTRATION; CELL STIMULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CPG ISLAND; CYTOKINE RELEASE; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME INDUCTION; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOSTIMULATION; LYMPH NODE CELL; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN INDUCTION; SHEEP;

2',5'-OLIGOADENYLATE SYNTHETASE; ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIVIRAL AGENTS; CATTLE; CELLS, CULTURED; FEMALE; IMMUNOGLOBULINS; INTERFERON TYPE II; INTERFERON-ALPHA; LEUKOCYTES, MONONUCLEAR; LYMPH NODES; MALE; OLIGODEOXYRIBONUCLEOTIDES; SHEEP; SKIN;

OVIS ARIES;

EID: 12144287264     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellimm.2004.01.004     Document Type: Article

References (68)

1. Krieg A.M., Yi A.K., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., Koretzky G.A., Klinman D.M. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature. 374:1995;546-549.
2. Krieg A.M., Wagner H. Causing a commotion in the blood: immunotherapy progresses from bacteria to bacterial DNA. Immunol. Today. 21:2000;521-526.
3. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., Akira S. A Toll-like receptor recognizes bacterial DNA. Nature. 408:2000;740-745.
4. Hartmann G., Weeratna R.D., Ballas Z.K., Payette P., Blackwell S., Suparto I., Rasmussen W.L., Waldschmidt M., Sajuthi D., Purcell R.H., Davis H.L., Krieg A.M. Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo. J. Immunol. 164:2000;1617-1624.
5. Rankin R., Pontarollo R., Ioannou X., Krieg A.M., Hecker R., Babiuk L.A., van Drunen Littel-van den Hurk S. CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved. Antisense Nucleic Acid Drug Dev. 11:2001;333-340.
6. Pontarollo R.A., Rankin R., Babiuk L.A., Godson D.L., Griebel P.J., Hecker R., Krieg A.M., van Drunen Littel-van den Hurk S. Monocytes are required for optimum in vitro stimulation of bovine peripheral blood mononuclear cells by non-methylated CpG motifs. Vet. Immunol. Immunopathol. 84:2002;43-59.
7. Kamstrup S., Verthelyi D., Klinman D.M. Response of porcine peripheral blood mononuclear cells to CpG-containing oligodeoxynucleotides. Vet. Microbiol. 78:2001;353-362.
8. Stacey K.J., Sweet M.J., Hume D.A. Macrophages ingest and are activated by bacterial DNA. J. Immunol. 157:1996;2116-2122.
9. Sparwasser T., Miethke T., Lipford G., Borschert K., Hacker H., Heeg K., Wagner H. Bacterial DNA causes septic shock. Nature. 386:1997;336-337.
10. Sparwasser T., Miethke T., Lipford G., Erdmann A., Hacker H., Heeg K., Wagner H. Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-alpha-mediated shock. Eur. J. Immunol. 27:1997;1671-1679.
11. Hartmann G., Krieg A.M. CpG DNA and LPS induce distinct patterns of activation in human monocytes. Gene Ther. 6:1999;893-903.
12. Yi A.K., Hornbeck P., Lafrenz D.E., Krieg A.M. CpG DNA rescue of murine B lymphoma cells from anti-IgM-induced growth arrest and programmed cell death is associated with increased expression of c-myc and bcl-xL. J. Immunol. 157:1996;4918-4925.
13. Redford T.W., Yi A.K., Ward C.T., Krieg A.M. Cyclosporin A enhances IL-12 production by CpG motifs in bacterial DNA and synthetic oligodeoxynucleotides. J. Immunol. 161:1998;3930-3935.
14. Ballas Z.K., Rasmussen W.L., Krieg A.M. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J. Immunol. 157:1996;1840-1845.
15. Jakob T., Walker P.S., Krieg A.M., Udey M.C., Vogel J.C. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J. Immunol. 161:1998;3042-3049.
16. Cowdery J.S., Chace J.H., Yi A.K., Krieg A.M. Bacterial DNA induces NK cells to produce IFN-gamma in vivo and increases the toxicity of lipopolysaccharides. J. Immunol. 156:1996;4570-4575.
17. Lipford G.B., Bendigs S., Heeg K., Wagner H. Poly-guanosine motifs costimulate antigen-reactive CD8 T cells while bacterial CpG-DNA affect T-cell activation via antigen-presenting cell-derived cytokines. Immunology. 101:2000;46-52.
18. Krug A., Rothenfusser S., Hornung V., Jahrsdorfer B., Blackwell S., Ballas Z.K., Endres S., Krieg A.M., Hartmann G. Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Eur. J. Immunol. 31:2001;2154-2163.
19. Yamamoto S., Yamamoto T., Kataoka T., Kuramoto E., Yano O., Tokunaga T. Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN (correction of INF) and augment IFN-mediated (correction of INF) natural killer activity. J. Immunol. 148:1992;4072-4076.
20. Krieg A.M., Love-Homan L., Yi A.K., Harty J.T. CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge. J. Immunol. 161:1998;2428-2434.
21. Elkins K.L., Rhinehart-Jones T.R., Stibitz S., Conover J.S., Klinman D.M. Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria. J. Immunol. 162:1999;2291-2298.
22. Gramzinski R.A., Doolan D.L., Sedegah M., Davis H.L., Krieg A.M., Hoffman S.L. Interleukin-12- and gamma interferon-dependent protection against malaria conferred by CpG oligodeoxynucleotide in mice. Infect. Immun. 69:2001;1643-1649.
23. Zimmermann S., Egeter O., Hausmann S., Lipford G.B., Rocken M., Wagner H., Heeg K. CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis. J. Immunol. 160:1998;3627-3630.
24. Walker P.S., Scharton-Kersten T., Krieg A.M., Love-Homan L., Rowton E.D., Udey M.C., Vogel J.C. Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-gamma-dependent mechanisms. Proc. Natl. Acad. Sci. USA. 96:1999;6970-6975.
25. Harandi A.M., Eriksson K., Holmgren J. A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection. J. Virol. 77:2003;953-962.
26. Olbrich A.R., Schimmer S., Heeg K., Schepers K., Schumacher T.N., Dittmer U. Effective postexposure treatment of retrovirus-induced disease with immunostimulatory DNA containing CpG motifs. J. Virol. 76:2002;11397-11404.
27. Gomis S., Babiuk L., Godson D.L., Allan B., Thrush T., Townsend H., Willson P., Waters E., Hecker R., Potter A. Protection of chickens against Escherichia coli infections by DNA containing CpG motifs. Infect. Immun. 71:2003;857-863.
28. Mutwiri G., Pontarollo R., Babiuk S., Griebel P., van Drunen Littel-van den Hurk S., Mena A., Tsang C., Alcon V., Nichani A., Ioannou X., Gomis S., Townsend H., Hecker R., Potter A., Babiuk L.A. Biological activity of immunostimulatory CpG DNA motifs in domestic animals. Vet. Immunol. Immunopathol. 91:2003;89-103.
29. Mena A., Nichani A.K., Popowych Y., Ioannou X.P., Godson D.L., Mutwiri G.K., Hecker R., Babiuk L.A., Griebel P. Bovine and ovine blood mononuclear leukocytes differ markedly in innate immune responses induced by class A and class B CpG-oligodeoxynucleotide. Oligonucleotides. 13:2003;245-259.
30. Ioannou X.P., Griebel P., Mena A., Gomis S.M., Godson D.L., Mutwiri G., Hecker R., Babiuk L.A., van Drunen Littel-van den Hurk S. Safety of CpG oligodeoxynucleotides in veterinary species. Antisense Nucleic Acid Drug Dev. 13:2003;157-167.
31. Ioannou X.P., Griebel P., Hecker R., Babiuk L.A., van Drunen Littel-van den Hurk S. The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligodeoxynucleotides. J. Virol. 76:2002;9002-9010.
32. Ioannou X.P., Gomis S.M., Karvonen B., Hecker R., Babiuk L.A., van Drunen Littel-van den Hurk S. CpG-containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpesvirus glycoprotein. Vaccine. 21:2002;127-137.
33. Mena A., Nichani A.K., Popowych Y., Godson D.L., Dent D., Townsend H.G.G., Mutwiri G.K., Hecker R., Babiuk L.A., Griebel P. Innate immune responses induced by CpG oligodeoxyribonucleotide stimulation of ovine blood mononuclear cells. Immunology. 110:2003;250-257.
34. Sands H., Gorey-Feret L.J., Cocuzza A.J., Hobbs F.W., Chidester D., Trainor G.L. Biodistribution and metabolism of internally 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate. Mol. Pharmacol. 45:1994;932-943.
35. Farman C.A., Kornbrust D.J. Oligodeoxynucleotide studies in primates: antisense and immune stimulatory indications. Toxicol. Pathol. 31(Suppl.):2003;119-122.
36. Gerdts V., Babiuk L.A., van Drunen Littel-van den Hurk H., Griebel P.J. Fetal immunization by a DNA vaccine delivered into the oral cavity. Nat. Med. 6:2000;929-932.
37. Mutwiri G., Bateman C., Baca-Estrada M.E., Snider M., Griebel P. Induction of immune responses in newborn lambs following enteric immunization with a human adenovirus vaccine vector. Vaccine. 19:2000;1284-1293.
38. Hughes H.P., Rossow S., Campos M., Rossi-Campos A., Janssen S., Godson D.L., Daflon B., Voirol M.J., Gerber C., Babiuk L.A. A slow release formulation for recombinant bovine interferon alpha I-1. Antiviral Res. 23:1994;33-44.
39. Nichani A.K., Mena A., Popowych Y., Dent D., Townsend H.G.G., Mutwiri G.K., Hecker R., Babiuk L.A., Griebel P.J. In vivo immunostimulatory effects of CpG oligodeoxynucleotide in cattle and sheep. Vet. Immunol. Immunopathol. 98:2004;17-29.
40. Griebel P., Hein W.R., Dudler L., Ferrari G. Phenotype and function of stromal cells cloned from the ileal Peyer's patch of sheep. Stem Cells. 11:1993;130-143.
41. Sen G.C., Ransohoff R.M. Interferon-induced antiviral actions and their regulation. Adv. Virus Res. 42:1993;57-102.
42. Shimada S., Yano O., Tokunaga T. In vivo augmentation of natural killer cell activity with a deoxyribonucleic acid fraction of BCG. Jpn. J. Cancer Res. 77:1986;808-816.
43. Yamamoto T., Yamamoto S., Kataoka T., Komuro K., Kohase M., Tokunaga T. Synthetic oligonucleotides with certain palindromes stimulate interferon production of human peripheral blood lymphocytes in vitro. Jpn. J. Cancer Res. 85:1994;775-779.
44. Hartmann G., Weiner G.J., Krieg A.M. CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells. Proc. Natl. Acad. Sci. USA. 96:1999;9305-9310.
45. Krieg A.M. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20:2002;709-760.
46. Salmon P., Le Cotonnec J.Y., Galazka A., Abdul-Ahad A., Darragh A. Pharmacokinetics and pharmacodynamics of recombinant human interferon-beta in healthy male volunteers. J. Interferon Cytokine Res. 16:1996;759-764.
47. Jacobs B.L., Langland J.O. When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. Virology. 219:1996;339-349.
48. ′ A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells Proc. Natl. Acad. Sci. USA. 75:1978;256-260.
49. ′ Oligo(A) polymerase activity and inhibition of viral RNA synthesis in interferon-treated HeLa cells Biochemistry. 18:1979;1765-1770.
50. ′ )oligoadenylate- dependent endonuclease Science. 212:1981;1030-1032.
51. ′ p)nA-dependent ribonuclease Nature. 289:1981;414-417.
52. ′ )oligoadenylate and activation of an endoribonuclease in interferon-treated HeLa cells infected with reovirus J. Virol. 42:1982;1039-1045.
53. Silverman R.H., Jung D.D., Nolan-Sorden N.L., Dieffenbach C.W., Kedar V.P., SenGupta D.N. Purification and analysis of murine 2-5A-dependent RNase. J. Biol. Chem. 263:1988;7336-7341.
54. ′ )(A)n-dependent endonucleases of different molecular mass Eur. J. Biochem. 179:1989;595-602.
55. Gursel M., Verthelyi D., Gursel I., Ishii K.J., Klinman D.M. Differential and competitive activation of human immune cells by distinct classes of CpG oligodeoxynucleotide. J. Leukoc. Biol. 71:2002;813-820.
56. Kadowaki N., Antonenko S., Liu Y.J. Distinct CpG DNA and polyinosinic-polycytidylic acid double-stranded RNA, respectively, stimulate CD11c- type 2 dendritic cell precursors and CD11c+ dendritic cells to produce type I IFN. J. Immunol. 166:2001;2291-2295.
57. Boggs R.T., McGraw K., Condon T., Flournoy S., Villiet P., Bennett C.F., Monia B.P. Characterization and modulation of immune stimulation by modified oligonucleotides. Antisense Nucleic Acid Drug Dev. 7:1997;461-471.
58. Krieg A.M. Now I know myCpGs. Trends Microbiol. 9:2001;249-252.
59. Ban E., Dupre L., Hermann E., Rohn W., Vendeville C., Quatannens B., Ricciardi-Castagnoli P., Capron A., Riveau G. CpG motifs induce Langerhans cell migration in vivo. Int. Immunol. 12:2000;737-745.
60. Behboudi S., Chao D., Klenerman P., Austyn J. The effects of DNA containing CpG motif on dendritic cells. Immunology. 99:2000;361-366.
61. Semple S.C., Klimuk S.K., Harasym T.O., Hope M.J. Lipid-based formulations of antisense oligonucleotides for systemic delivery applications. Methods Enzymol. 313:2000;322-341.
62. Semple S.C., Klimuk S.K., Harasym T.O., Dos Santos N., Ansell S.M., Wong K.F., Maurer N., Stark H., Cullis P.R., Hope M.J., Scherrer P. Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures. Biochim. Biophys. Acta. 1510:2001;152-166.
63. Zhang Y.M., Rusckowski M., Liu N., Hnatowich D.J. Cationic liposomes enhance cellular/nuclear localization of Tc-99m-antisense oligonucleotides in target tumor cells. Cancer Biother. Radiopharmaceuticals. 16:2001;411-419.
64. Duzgunes N., Simoes S., Slepushkin V., Pretzer E., Rossi J.J., De Clercq E., Antao V.P., Collins M.L., de Lima M.C. Enhanced inhibition of HIV-1 replication in macrophages by antisense oligonucleotides, ribozymes and acyclic nucleoside phosphonate analogs delivered in pH-sensitive liposomes. Nucleosides Nucleotides Nucleic Acids. 20:2001;515-523.
65. Agrewala J.N., Owais M., Gupta C.M., Mishra G.C. Antigen incorporation into liposomes results in the enhancement of IL-4 and IgG1 secretion: evidence for preferential expansion of Th-2 cells. Cytokines Mol. Ther. 2:1996;59-65.
66. Mui B., Raney S.G., Semple S.C., Hope M.J. Immune stimulation by a CpG-containing oligodeoxynucleotide is enhanced when encapsulated and delivered in lipid particles. J. Pharmacol. Exp. Therapeutics. 298:2001;1185-1192.
67. Gursel I., Gursel M., Ishii K.J., Klinman D.M. Sterically stabilized cationic liposomes improve the uptake and immunostimulatory activity of CpG oligonucleotides. J. Immunol. 167:2001;3324-3328.
68. Stacey K.J., Blackwell J.M. Immunostimulatory DNA as an adjuvant in vaccination against Leishmania major. Infect. Immun. 67:1999;3719-3726.